This proposal for Stanford University to act a the PEGT Coordinator and Data Core Support function is directed towards leveraging the current computer and networking capabilities of the Department of Statistics and Division of Biostatistics in order to quickly get computer and networking systems support operational on a day-to-day basis for the comprehensive Programs of Excellence in Gene Therapy program. New computer systems dedicated to the PEGT program will then be purchased, installed, and brought online during the first year of the grant. The networking infrastructure and the technical support functions provided by Stanford University and the School of Medicine will be utilized for all PEGT systems. Remote PEGT systems will be supported directly by TBN personnel as will be discussed. Dr. Balasubramanian (Naras) Narsimhan, computer expert for both the Department of Statistics and the Division of Biostatistics will provide expert advice and counsel as needed. Our objectives are to: 1. Provide state-of-the-art communications capability in order to support: management oversight by the Inter-Program Steering Committee, secure data entry and access, and dissemination of information. Appropriate manuals and guidance will be provided. For example, our manual of procedures will be available over the project Web site. When necessary, travel and training will be provided by members of our site to those at others. 2. Purchase, install and support computer systems with a view towards sustainability. 3. Make extensive use of the user-friendly nature of the Web in providing services and access for users. 4. Provide stability, redundancy, and data security to maintain the PEGT Network over the five year period. Stanford's well known expertise in all manner of computer efforts is nurtured by its close proximity and relationship to Silicon Valley companies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL066948-03
Application #
6664076
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$248,651
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Margaritis, Paris (2010) Long-term expression of canine FVIIa in hemophilic dogs. Thromb Res 125 Suppl 1:S60-2
Margaritis, Paris; Roy, Elise; Aljamali, Majed N et al. (2009) Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood 113:3682-9
Bedi, Maninder S; Alvarez Jr, Rene J; Kubota, Toru et al. (2008) Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support. Clin Transl Sci 1:245-8
Aljamali, Majed N; Margaritis, Paris; Schlachterman, Alexander et al. (2008) Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J Clin Invest 118:1825-34
Akache, Bassel; Grimm, Dirk; Shen, Xuan et al. (2007) A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Mol Ther 15:330-9
Callan, M B; Aljamali, M N; Margaritis, P et al. (2006) A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 4:2616-22
Akache, Bassel; Grimm, Dirk; Pandey, Kusum et al. (2006) The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol 80:9831-6
Jiang, Haiyan; Couto, Linda B; Patarroyo-White, Susannah et al. (2006) Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 108:3321-8
Chen, Jian; Wu, Qi; Yang, Pingar et al. (2006) Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy. Mol Ther 13:260-9
Bedi, Maninder; McNamara, Dennis; London, Barry et al. (2006) Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm 3:808-12

Showing the most recent 10 out of 36 publications